MoneyWorks4Me

Colinz Laboratories - Quaterly Results

16 May 2025 Evaluate
Net sales declined -10.93%  to  Rs. 14.51 million from Rs. 16.29 millions.Net profit stood at Rs. 1.50  millions  compared to Rs. 1.34 millions in the corresponding previous quarter,high by 11.94%.Operating profit for the quarter ended March 2025 decreased to 1.74 millions as compared to 2.31 millions of corresponding quarter ended March 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 14.51 16.29 -10.93 65.28 70.30 -7.14 65.28 70.30 -7.14
Other Income 0.76 1.07 -28.97 2.98 2.75 8.36 2.98 2.75 8.36
PBIDT 1.74 2.31 -24.68 7.94 8.17 -2.82 7.94 8.17 -2.82
Interest 0.16 0.10 60.00 0.42 0.37 13.51 0.42 0.37 13.51
PBDT 1.58 2.21 -28.51 7.52 7.80 -3.59 7.52 7.80 -3.59
Depreciation 0.35 0.33 6.06 1.31 1.30 0.77 1.31 1.30 0.77
PBT 1.23 1.88 -34.57 6.21 6.50 -4.46 6.21 6.50 -4.46
TAX -0.27 0.54 -150.00 1.23 1.64 -25.00 1.23 1.64 -25.00
Deferred Tax -0.52 -0.02 2500.00 -0.52 -0.02 2500.00 -0.52 -0.02 2500.00
PAT 1.50 1.34 11.94 4.98 4.86 2.47 4.98 4.86 2.47
Equity 25.19 25.19 0.00 25.19 25.19 0.00 25.19 25.19 0.00
PBIDTM(%) 11.99 14.18 -15.44 12.16 11.62 4.66 12.16 11.62 4.66
Peers
Company Name CMP
Sun Pharma. Inds. 1840.00
Dr. Reddys Labs. 1222.50
Cipla 1388.90
Lupin 2061.85
Zydus Lifesciences 1212.00
View more..